439
Views
18
CrossRef citations to date
0
Altmetric
Review Article

Metabolic pathways and pharmacokinetics of natural medicines with low permeability

, , , , &
Pages 464-476 | Received 25 Jun 2017, Accepted 03 Sep 2017, Published online: 14 Sep 2017

References

  • Ahmad N, Ahmad R, Naqvi AA, Alam MA, Ashafaq M, Samim M, Iqbal Z, Ahmad FJ. 2016. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of cerebral ischemia. Int J Biol Macromol. 91:640–655.
  • Akao T, Kawabata K, Yanagisawa E, Ishihara K, Mizuhara Y, Wakui Y, Sakashita Y, Kobashi K. 2000. Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol. 52:1563–1568.
  • Almazroo OA, Miah MK, Venkataramanan R. 2017. Drug metabolism in the liver. Clin Liver Dis. 21:1–20.
  • Amidon GL, Lennernas H, Shah VP, Crison JR. 1995. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 12:413–420.
  • Awasthi P, Gupta AP, Bedi YS, Vishwakarma RA, Gandhi SG. 2016. Mannitol stress directs flavonoid metabolism toward synthesis of flavones via differential regulation of two cytochrome P450 monooxygenases in coleus forskohlii. Front Plant Sci. 7:985.
  • Backman JT, Filppula AM, Niemi M, Neuvonen PJ. 2016. Role of cytochrome P450 2C8 in drug metabolism and interactions. Pharmacol Rev. 68:168–241.
  • Benedetti MS, Whomsley R, Poggesi I, Cawello W, Mathy F-X, Delporte M-L, Papeleu P, Watelet J-B. 2009. Drug metabolism and pharmacokinetics. Drug Metab Rev. 41:344–390.
  • Bilia AR, Piazzini V, Guccione C, Risaliti L, Asprea M, Capecchi G, Bergonzi MC. 2017. Improving on nature: the role of nanomedicine in the development of clinical natural drugs. Planta Med. 83:366–381.
  • Chen H, Chen Y, Du P, Han F. 2007. Structural elucidation of in vivo and in vitro metabolites of anisodine by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 44:773–778.
  • Chen J, Yan G-j, Hu R-r, Gu Q-w, Chen M-l, Gu W, Chen Z-P, Cai B-c. 2012. Improved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholine. Int J Nanomed. 7:3567–3577.
  • Chen J-Y, Wu H, Li H, Hu S-L, Dai M-m, Chen J. 2015. Anti-inflammatory effects and pharmacokinetics study of geniposide on rats with adjuvant arthritis. Int Immunopharmacol. 24:102–109.
  • Chen Y, Chen HX, Du P, Han FM. 2005. HPLC-electrospray ionization ion trap tandem mass spectrometry analysis of oxymatrine and its metabolites in rat urine. Yao Xue Xue Bao. 40:740–745. Written in Chinese.
  • Cragg G, Newman D. 2014. Natural products and drug discovery and development: a history of success and continuing promise for the future. Planta Med. 80:750–750.
  • Curry TB, Matteson EL, Stewart AK. 2017. Introduction to the symposium on precision medicine. Mayo Clin Proc. 92:4–6.
  • Dahan A, Miller JM, Amidon GL. 2009. Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs. AAPS J. 11:740–746.
  • Dang XW, Qing L. 2012. Pharmacokinetic study of syringin in rat plasma. Chin Tradit Pat Med. 34:1246–1249.
  • Dang YJ, Zhu CY. 2009. Determination of trace cantharidin in plasma and pharmacokinetic study in beagle dogs using gas chromatography-mass spectrometry. J Anal Toxicol. 33:384–388.
  • Dang YJ, Hu CH, An LN, Zhu CY. 2010. Study of the physicochemical properties and oral bioavailability of the solid dispersion of cantharidin with polyethylene glycol 4000. Methods Find Exp Clin Pharmacol. 32:157–162.
  • Dong Z-X, Shi Z-H, Li N-G, Zhang W, Gu T, Zhang P-X, Wu W-Y, Tang Y-P, Fang F, Xue X, et al. 2016. Design, synthesis, and biological evaluation of scutellarein derivatives based on scutellarin metabolic mechanism in vivo. Chem Biol Drug Des. 87:946–957.
  • Dressman JB, Reppas C. 2000. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci. 11:S73–S80.
  • Dvorak Z. 2016. Opportunities and challenges in using human hepatocytes in cytochromes P450 induction assays. Expert Opin Drug Metab Toxicol. 12:169–174.
  • Fan HX, Deng ZP, Zhong H, Xu XT, Yao QQ. 2014. Comparative pharmacokinetics of syringin, eleutheroside E and isofraxidin in rat plasma after intravenous administration of each monomer and Ciwujia injection. Chin J Chin Mater Med. 39:1921–1927.
  • Fan L, Zhang W, Guo D, Tan Z-R, Xu P, Li Q, Liu Y-Z, Zhang L, He T-Y, Hu D-L, et al. 2008. The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1. Clin Pharmacol Ther. 83:471–476.
  • Feng Y, Sun C, Yuan Y, Zhu Y, Wan J, Firempong CK, Omari-Siaw E, Xu Y, Pu Z, Yu J, et al. 2016. Enhanced oral bioavailability and in vivo antioxidant activity of chlorogenic acid via liposomal formulation. Int J Pharm. 501:342–349.
  • Fong SYK, Liu M, Wei H, Löbenberg R, Kanfer I, Lee VHL, Amidon GL, Zuo Z. 2013. Establishing the pharmaceutical quality of Chinese herbal medicine: a provisional BCS classification. Mol Pharm. 10:1623–1643.
  • Fox BI, Felkey BG. 2016. Precision medicine: considerable potential combined with important challenges. Hosp Pharm. 51:950–951.
  • Hao H, Zheng X, Wang G. 2014. Insights into drug discovery from natural medicines using reverse pharmacokinetics. Trends Pharmacol Sci. 35:168–177.
  • Harwansh RK, Mukherjee PK, Bahadur S, Biswas R. 2015. Enhanced permeability of ferulic acid loaded nanoemulsion based gel through skin against UVA mediated oxidative stress. Life Sci. 141:202–211.
  • Hiratsuka M. 2016. Genetic polymorphisms and in vitro functional characterization of CYP2C8, CYP2C9, and CYP2C19 allelic variants. Biol Pharm Bull. 39:1748–1759.
  • Huang J, Li N, Yu Y, Weng W, Huang X. 2006. Determination of aglycone conjugated metabolites of scutellarin in rat plasma by HPLC. J Pharm Biomed Anal. 40:465–471.
  • Huang Y, Zhi DG, Wei-Ren XU, Liu CX. 2006. Pharmacokinetics of anisodine in beagle dogs serum by LC-MS. Chin Tradit Herbal Drugs. 37:1214–1217.
  • Imig JD, Khan MA. 2015. Cytochrome P450 and lipoxygenase metabolites on renal function. Compr Physiol. 6:423–441.
  • Jian T-Y, He J-C, He G-H, Feng E-F, Li H-L, Bai M, Xu G-L. 2012. Scutellarin inhibits cytochrome P450 isoenzyme 1A2 (CYP1A2) in rats. Phytother Res. 26:1226–1230.
  • Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S. 2011. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm. 420:1–10.
  • Li B, Wu J, Li X. 2013. Simultaneous determination and pharmacokinetic study of stachydrine and leonurine in rat plasma after oral administration of herba leonuri extract by LC-MS/MS. J Pharm Biomed Anal. 76:192–199.
  • Li C, Yao Z-H, Qin Z-F, Zhang J-B, Cao R-Y, Dai Y, Yao X-S. 2014. Isolation and identification of phase I metabolites of phillyrin in rats. Fitoterapia. 97:92–97.
  • Li M, Shi A, Pang H, Xue W, Li Y, Cao G, Yan B, Dong F, Li K, Xiao W, et al. 2014. Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects. J Ethnopharmacol. 156:210–215.
  • Li Q, Sun L-X, Xu L, Jia Y, Wang Z-W, Shen Z-D, Bi K-S. 2006. Determination and pharmacokinetic study of syringin and chlorogenic acid in rat plasma after administration of aidi lyophilizer. Biomed Chromatogr. 20:1315–1320.
  • Li X, Wang K, Wei W, Liu Y-y, Gong L. 2013. In vitro metabolism of brucine by human liver microsomes and its interactions with CYP substrates. Chem Biol Interact. 204:140–143.
  • Li Y, Liu C, Zhang Y, Mi S, Wang N. 2011. Pharmacokinetics of ferulic acid and potential interactions with Honghua and clopidogrel in rats. J Ethnopharmacol. 137:562–567.
  • Li Y-X, Peng C, Zhang R-Q, Li X, Jiang X-H. 2009. Pharmacokinetics of phillyrin and forsythiaside following iv administration to beagle dog. Eur J Drug Metab Pharmacokinet. 34:79–83.
  • Lin A, Su X, She D, Qiu K, He Q, Liu Y. 2016. LC-MS/MS determination and comparative pharmacokinetics of strychnine, brucine and their metabolites in rat plasma after intragastric administration of each monomer and the total alkaloids from semen strychni. J Chromatogr B Analyt Technol Biomed Life Sci. 1008:65–73.
  • Liu W, Shi J, Zhu L, Dong L, Luo F, Zhao M, Wang Y, Hu M, Lu L, Liu Z, et al. 2015. Reductive metabolism of oxymatrine is catalyzed by microsomal CYP3A4. Drug Des Devel Ther. 9:5771–5783.
  • Liu X, Ding Y, Zhao B, Liu Y, Luo S, Wu J, Li J, Xiang D. 2016. In vitro and in vivo evaluation of puerarin-loaded PEGylated mesoporous silica nanoparticles. Drug Dev Ind Pharm. 42:2031–2037.
  • Liu XH, Pan LL, Gong QH, Zhu YZ. 2010. Antiapoptotic effect of novel compound from herba leonuri-leonurine (SCM-198): a mechanism through inhibition of mitochondria dysfunction in H9c2 cells. Curr Pharm Biotechnol. 11:895–905.
  • Ma G-Y, Cao Y-F, Hu C-M, Fang Z-Z, Sun X-Y, Hong M, Zhu Z-T. 2014. Comparison of inhibition capability of scutellarein and scutellarin towards important liver UDP-glucuronosyltransferase (UGT) isoforms. Phytother Res. 28:282–286.
  • Mateos R, Goya L, Bravo L. 2006. Uptake and metabolism of hydroxycinnamic acids (chlorogenic, caffeic, and ferulic acids) by HepG2 cells as a model of the human liver. J Agric Food Chem. 54:8724–8732.
  • Maussang D, Rip J, van Kregten J, van den Heuvel A, van der Pol S, van der Boom B, Reijerkerk A, Chen L, de Boer M, Gaillard P, et al. 2016. Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo. Drug Discov Today Technol. 20:59–69.
  • Mills CE, Tzounis X, Oruna-Concha M-J, Mottram DS, Gibson GR, Spencer JPE. 2015. In vitro colonic metabolism of coffee and chlorogenic acid results in selective changes in human faecal microbiota growth. Brit J Nutr. 113:1–8.
  • Moghaddam E, Teoh B-T, Sam S-S, Lani R, Hassandarvish P, Chik Z, Yueh A, Abubakar S, Zandi K. 2014. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci Rep. 4:5452.
  • Noh K, Kang Y, Nepal MR, Jeong KS, Oh DG, Kang MJ, Lee S, Kang W, Jeong HG, Jeong TC, et al. 2016. Role of intestinal microbiota in baicalin-induced drug interaction and its pharmacokinetics. Molecules. 21:337
  • Oda S, Fukami T, Yokoi T, Nakajima M. 2015. A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development. Drug Metab Pharmacokinet. 30:30–51.
  • Oh DM, Curl RL, Amidon GL. 1993. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm Res. 10:264–270.
  • Poquet L, Clifford MN, Williamson G. 2008. Transport and metabolism of ferulic acid through the colonic epithelium. Drug Metab Dispos. 36:190–197.
  • Qu H-H, Sun Y, Wu T-T, Zhang G-L, Cheng J-J, Wang X-Q, Feng H-B, Zhao Y, Wang Q-G. 2014. Pharmacokinetics of geniposide by monoclonal antibody-based icELISA in mice after oral administration of Huanglian-Jiedu-Tang. Biol Pharm Bull. 37:1525–1533.
  • Rehman SU, Kim IS, Kang KS, Yoo HH. 2015. HPLC determination of esculin and esculetin in rat plasma for pharmacokinetic studies. J Chromatogr Sci. 53:1322–1327.
  • Santos BL, Oliveira MN, Coelho PLC, Pitanga BPS, da Silva AB, Adelita T, Silva VDA, Costa MD, El-Bachá RS, Tardy M, et al. 2015. Flavonoids suppress human glioblastoma cell growth by inhibiting cell metabolism, migration, and by regulating extracellular matrix proteins and metalloproteinases expression. Chem Biol Interact. 242:123–138.
  • Sheng JQ, Zhang CH, Tu XY, Wei XX, Li Y, Xu GL. 2014. Effects of puerarin on insulin resistance in HepG2 cell line. Lishizhen Med Mater Med Res. 25:1831–1833.
  • Shi S, Zhang RT, Shang XY, Wang N, Sen LI, Zhang ZS. 2014. Effect of puerarin on serum uric acid in hyperuricemic rats. Food Sci Technol. 39:216–219.
  • Shi Z-H, Li N-G, Wang Z-J, Tang Y-P, Dong Z-X, Zhang W, Zhang P-X, Gu T, Wu W-Y, Yang J-P, Duan J-A. 2015. Synthesis and biological evaluation of methylated scutellarein analogs based on metabolic mechanism of scutellarin in vivo. Eur J Med Chem. 106:95–105.
  • Su K-Y, Yu CY, Chen Y-P, Hua K-F, Chen Y-LS. 2014. 3,4-Dihydroxytoluene, a metabolite of rutin, inhibits inflammatory responses in lipopolysaccharide-activated macrophages by reducing the activation of NF-κB signaling. BMC Complement Altern Med. 14:184–194.
  • Tan B, Cai W, Zhang J, Zhou N, Ma G, Yang P, Zhu Q, Zhu Y. 2014. Identification of UDP-glucuronosyltransferase isoforms responsible for leonurine glucuronidation in human liver and intestinal microsomes. Xenobiotica. 44:775–784.
  • Tian F, Li C, Wang X, Ren S, Li N, Liu Q, Zhou S, Lu Y, Zhao D, Chen X, et al. 2015. Comparative study on pharmacokinetics of a series of anticholinergics, atropine, anisodamine, anisodine, scopolamine and tiotropium in rats. Eur J Drug Metab Pharmacokinet. 40:245–253.
  • Tian J-X, Peng C, Xu L, Tian Y, Zhang Z-J. 2013. In vitro metabolism study of strychnos alkaloids using high-performance liquid chromatography combined with hybrid ion trap/time-of-flight mass spectrometry. Biomed Chromatogr. 27:775–783.
  • Tian J-X, Wang M, Xu L, Tian Y, Song R, Xu F-G, Zhang Z-J. 2014. Metabolism of brucine: the important metabolic pathways of dihydroindole-type alkaloid for excretion in rats. Bioanalysis. 6:137–149.
  • Umarani V, Muvvala S, Ramesh A, Lakshmi BVS, Sravanthi N. 2015. Rutin potentially attenuates fluoride-induced oxidative stress-mediated cardiotoxicity, blood toxicity and dyslipidemia in rats. Toxicol Mech Methods. 25:143–149.
  • Varma MV, Gardner I, Steyn SJ, Nkansah P, Rotter CJ, Whitney-Pickett C, Zhang H, Di L, Cram M, Fenner KS, et al. 2012. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery. Mol Pharm. 9:1199–1212.
  • Wang JW, Chiang MH, Lu CM, Tsai TH. 2016. Determination the active compounds of herbal preparation by UHPLC-MS/MS and its application on the preclinical pharmacokinetics of pure ephedrine, single herbal extract of ephedra, and a multiple herbal preparation in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 1026:152–161.
  • Wang JX, Huang HZ, Li N, Gao CK. 2014. Study on self-microemulsifying membrane controlled-release drop pill of hawthorn leaves flavonoids. Chin J Chin Mate Med. 39:821–827.
  • Wang Y, Ao H, Qian Z, Zheng Y. 2011. Intestinal transport of scutellarein and scutellarin and first-pass metabolism by UDP-glucuronosyltransferase-mediated glucuronidation of scutellarein and hydrolysis of scutellarin. Xenobiotica. 41:538–548.
  • Wang Y, Yang J, Li X, Wang J. 2012. The metabolism of baicalin in rat and the biological activities of the metabolites. Evid Based Complement Alternat Med. 2012:404529.
  • Wang Y, Zhao M, Ou Y, Zeng B, Lou X, Wang M, Zhao C. 2016. Metabolic profile of esculin in rats by ultra high performance liquid chromatography combined with fourier transform ion cyclotron resonance mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 1020:120–128.
  • Wei P, Huo H-l, Ma Q-h, Li H-c, Xing X-f, Tan X-m, Luo J-b. 2014. Pharmacokinetic comparisons of five ephedrine alkaloids following oral administration of four different Mahuang-Guizhi herb-pair aqueous extracts ratios in rats. J Ethnopharmacol. 155:642–648.
  • Xie C, Zhong DF, Chen XY. 2011. Metabolites of injected chlorogenic acid in rats. Acta Pharm Sin. 46:88–95.
  • Xu X, Li R, Chen G, Hoopes SL, Zeldin DC, Wang DW. 2016. The role of cytochrome P450 epoxygenases, soluble epoxide hydrolase, and epoxyeicosatrienoic acids in metabolic diseases. Adv Nutr. 7:1122–1128.
  • Xu X, Zhang S, Zhang L, Yan W, Zheng X. 2005. The neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. Planta Med. 71:585–591.
  • Xu XH, Zheng XX, Zhou Q, Li H. 2007. Inhibition of excitatory amino acid efflux contributes to protective effects of puerarin against cerebral ischemia in rats. Biomed Environ Sci. 20:336–342.
  • Yan T, Fu Q, Wang J, Ma S. 2015. UPLC-MS/MS determination of ephedrine, methylephedrine, amygdalin and glycyrrhizic acid in beagle plasma and its application to a pharmacokinetic study after oral administration of Mahuang Tang. Drug Test Anal. 7:158–163.
  • Yang J, Qian D, Jiang S, Shang E-x, Guo J, Duan J-a. 2012. Identification of rutin deglycosylated metabolites produced by human intestinal bacteria using UPLC-Q-TOF/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 898:95–100.
  • Yin ZZ, Zhang LY, Xu LN. 1980. The effect of Dangui (angelica sinensis) and its Ingredient ferulic acid on rat plateletaggregation and release of 5-HT. Acta Pharm Sin. 15:321–326.
  • Yu T, Ji P, Zhao WM. 2015. Preparation of baicalein liposome-lyophilized powder and Its pharmacokinetics study. Chin Med Mat. 38:2404–2407.
  • Yuan F, Chen J, Wu W-J, Chen S-Z, Wang X-D, Su Z, Huang M. 2010. Effects of matrine and oxymatrine on catalytic activity of cytochrome p450s in rats. Basic Clin Pharmacol Toxicol. 107:906–913.
  • Zhang S, Wang J, Pan J. 2016. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Deliv. 23:3696–3703.
  • Zhang X, Liu S, Pi Z, Liu Z, Song F. 2017. Simultaneous quantification method for comparative pharmacokinetics studies of two major metabolites from geniposide and genipin by online mircrodialysis-UPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 1041–1042:11–18.
  • Zhang X, Song J, Shi X, Miao S, Li Y, Wen A. 2013. Absorption and metabolism characteristics of rutin in Caco-2 cells. ScientificWorldJ. 2013:382350.
  • Zhang Y, Li Z, Zhang K, Yang G, Wang Z, Ahao J, Hu R, Feng R. 2016. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles. Int J Pharm. 511:57–64.
  • Zhao Y-Z, Zhang L, Gupta PK, Tian F-R, Mao K-L, Qiu K-Y, Yang W, Lv C-Z, Lu C-T. 2016. Using PG-liposome-based system to enhance puerarin liver-targeted therapy for alcohol-induced liver disease. AAPS Pharm Sci Tech. 17:1376–1382.
  • Zheng Z, Yan T, Chen W, Ye L, Tang L, Liu Z. 2012. Pharmacokinetic determination of ephedrine in herba ephedrae and Wutou Tang decoctions in rats using ultra performance liquid chromatography tandem mass spectrometry. Xenobiotica. 42:775–783.
  • Zhong S, Liu J, Ren X, Zhang J, Zhou S, Xu X-P. 2008. Pharmacokinetics and excretion of chlorogenic acid in beagle dogs. Pharmazie. 63:520–524.
  • Zhu Q, Zhang J, Yang P, Tan B, Liu X, Zheng Y, Cai W, Zhu Y. 2014. Characterization of metabolites of leonurine (SCM-198) in rats after oral administration by liquid chromatography/tandem mass spectrometry and NMR spectrometry. ScientificWorldJ. 2014:947946.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.